| Year |
Citation |
Score |
| 2018 |
Cavaco BM, Canaff L, Nolin-Lapalme A, Vieira M, Silva T, Saramago A, Domingues R, Rutter MM, Hudon J, Gleason JL, Leite V, Hendy GN. Homozygous calcium-sensing receptor polymorphism R544Q presents as hypocalcemic hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. PMID 29846619 DOI: 10.1210/Jc.2017-02407 |
0.331 |
|
| 2017 |
Cinque L, Sparaneo A, Penta L, Mencarelli A, Rogaia D, Esposito S, Fabrizio FP, Baorda F, Verrotti A, Falorni A, Stangoni G, Hendy GN, Guarnieri V, Prontera P. Novel Autosomal Dominant PTH Gene Signal Sequence Mutation in a Family with Familial Isolated Hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. PMID 28938448 DOI: 10.1210/Jc.2017-00250 |
0.457 |
|
| 2017 |
Guarnieri V, Seaberg RM, Kelly C, Jean Davidson M, Raphael S, Shuen AY, Baorda F, Palumbo O, Scillitani A, Hendy GN, Cole DEC. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family. Bmc Medical Genetics. 18: 83. PMID 28774260 DOI: 10.1186/S12881-017-0445-0 |
0.353 |
|
| 2017 |
Cinque L, Sparaneo A, Cetani F, Coco M, Clemente C, Chetta M, Balsamo T, Battista C, Sanpaolo E, Pardi E, D'Agruma L, Marcocci C, Maiello E, Hendy GN, Cole DEC, et al. Novel association of MEN1 gene mutations with parathyroid carcinoma. Oncology Letters. 14: 23-30. PMID 28693130 DOI: 10.3892/Ol.2017.6162 |
0.356 |
|
| 2016 |
Obermannova B, Sumnik Z, Dusatkova P, Cinek O, Grant M, Lebl J, Hendy GN. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study. European Journal of Endocrinology / European Federation of Endocrine Societies. 174: K1-K11. PMID 26764418 DOI: 10.1530/EJE-15-1216 |
0.355 |
|
| 2016 |
Hendy GN, Canaff L. Calcium-sensing receptor, proinflammatory cytokines and calcium homeostasis. Seminars in Cell & Developmental Biology. 49: 37-43. PMID 26612442 DOI: 10.1016/j.semcdb.2015.11.006 |
0.324 |
|
| 2015 |
Goltzman D, Hendy GN. The calcium-sensing receptor in bone--mechanistic and therapeutic insights. Nature Reviews. Endocrinology. 11: 298-307. PMID 25752283 DOI: 10.1038/Nrendo.2015.30 |
0.351 |
|
| 2015 |
Carmosino M, Gerbino A, Hendy GN, Torretta S, Rizzo F, Debellis L, Procino G, Svelto M. NKCC2 activity is inhibited by the Bartter's syndrome type 5 gain-of-function CaR-A843E mutant in renal cells. Biology of the Cell / Under the Auspices of the European Cell Biology Organization. 107: 98-110. PMID 25631355 DOI: 10.1111/Boc.201400069 |
0.34 |
|
| 2015 |
Goltzman D, Hendy GN, White JH. Vitamin D and its receptor during late development. Biochimica Et Biophysica Acta. 1849: 171-180. PMID 24939836 DOI: 10.1016/J.Bbagrm.2014.05.026 |
0.417 |
|
| 2015 |
Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Macrina L, Mingione A, Brasacchio C, Eller-Vainicher C, Cusi D, Spada A, Cole DE, Hendy GN, et al. Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene. Journal of Nephrology. 28: 67-72. PMID 24832896 DOI: 10.1007/S40620-014-0106-8 |
0.333 |
|
| 2015 |
Hendy GN, Cole DEC. Familial isolated hypoparathyroidism Hypoparathyroidism. 167-175. DOI: 10.1007/978-88-470-5376-2_16 |
0.445 |
|
| 2014 |
D'Agruma L, Coco M, Guarnieri V, Battista C, Canaff L, Salcuni AS, Corbetta S, Cetani F, Minisola S, Chiodini I, Eller-Vainicher C, Spada A, Marcocci C, Guglielmi G, Zini M, ... ... Hendy GN, et al. Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts. The Journal of Clinical Endocrinology and Metabolism. 99: E2794-8. PMID 25279501 DOI: 10.1210/Jc.2014-2857 |
0.321 |
|
| 2014 |
Thompson MD, Hendy GN, Percy ME, Bichet DG, Cole DE. G protein-coupled receptor mutations and human genetic disease. Methods in Molecular Biology (Clifton, N.J.). 1175: 153-87. PMID 25150870 DOI: 10.1007/978-1-4939-0956-8_8 |
0.388 |
|
| 2014 |
Eller-Vainicher C, Battista C, Guarnieri V, Muscarella S, Palmieri S, Salcuni AS, Guglielmi G, Corbetta S, Minisola S, Spada A, Hendy GN, Cole DE, Chiodini I, Scillitani A. Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism. European Journal of Endocrinology / European Federation of Endocrine Societies. 171: 399-406. PMID 24966175 DOI: 10.1530/Eje-14-0343 |
0.31 |
|
| 2014 |
Atay Z, Bereket A, Haliloglu B, Abali S, Ozdogan T, Altuncu E, Canaff L, Vilaça T, Wong BY, Cole DE, Hendy GN, Turan S. Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet. Bone. 64: 102-7. PMID 24735972 DOI: 10.1016/J.Bone.2014.04.010 |
0.464 |
|
| 2014 |
Hendy GN, Canaff L, Newfield RS, Tripto-Shkolnik L, Wong BY, Lee BS, Cole DE. Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations. The Journal of Clinical Endocrinology and Metabolism. 99: E1311-5. PMID 24731014 DOI: 10.1210/Jc.2014-1120 |
0.46 |
|
| 2013 |
Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, Battista C, Copetti M, Kotzot D, Kapelari K, Al-Abdulrazzaq D, Perlman K, Sochett E, Cole DE, Pellegrini F, ... ... Hendy GN, et al. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene. Plos One. 8: e82292. PMID 24340015 DOI: 10.1371/Journal.Pone.0082292 |
0.421 |
|
| 2013 |
Hendy GN, Cole DE. Ruling in a suspect: the role of AP2S1 mutations in familial hypocalciuric hypercalcemia type 3. The Journal of Clinical Endocrinology and Metabolism. 98: 4666-9. PMID 24311792 DOI: 10.1210/Jc.2013-3616 |
0.495 |
|
| 2013 |
Vezzoli G, Terranegra A, Aloia A, Arcidiacono T, Milanesi L, Mosca E, Mingione A, Spotti D, Cusi D, Hou J, Hendy GN, Soldati L, Paloschi V, Dogliotti E, et al. Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasis. The Journal of Clinical Endocrinology and Metabolism. 98: 3839-47. PMID 23864702 DOI: 10.1210/Jc.2013-1834 |
0.402 |
|
| 2013 |
Hendy GN, Canaff L, Cole DE. The CASR gene: alternative splicing and transcriptional control, and calcium-sensing receptor (CaSR) protein: structure and ligand binding sites. Best Practice & Research. Clinical Endocrinology & Metabolism. 27: 285-301. PMID 23856260 DOI: 10.1016/J.Beem.2013.02.009 |
0.401 |
|
| 2013 |
Hendy GN, Cole DE. Genetic defects associated with familial and sporadic hyperparathyroidism. Frontiers of Hormone Research. 41: 149-65. PMID 23652676 DOI: 10.1159/000345675 |
0.363 |
|
| 2012 |
Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D'Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, ... ... Hendy GN, et al. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Cellular Oncology (Dordrecht). 35: 411-22. PMID 22987117 DOI: 10.1007/S13402-012-0100-X |
0.315 |
|
| 2012 |
Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, Kitazawa R, Komori T, Sugimoto T, Seino S, Kaji H. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone. 51: 158-67. PMID 22579779 DOI: 10.1016/J.Bone.2012.04.017 |
0.364 |
|
| 2012 |
Canaff L, Vanbellinghen JF, Kaji H, Goltzman D, Hendy GN. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1). The Journal of Biological Chemistry. 287: 8584-97. PMID 22275377 DOI: 10.1074/Jbc.M112.341958 |
0.364 |
|
| 2012 |
Canaff L, Vanbellinghen JF, Kanazawa I, Kwak H, Garfield N, Vautour L, Hendy GN. Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA. The Journal of Clinical Endocrinology and Metabolism. 97: E282-91. PMID 22090276 DOI: 10.1210/Jc.2011-0241 |
0.359 |
|
| 2012 |
Cole DEC, Hendy GN. Clinical consequences of CASR mutation in the first few years of life Bone. 51. DOI: 10.1016/J.Bone.2012.08.089 |
0.304 |
|
| 2012 |
Vezzoli G, Aloia A, Terranegra A, Dogliotti E, Arcidiacono T, Rainone F, Mingione A, Spotti D, Cusi D, Hendy GN, Soldati L. Polymorphisms of CaSR gene decreasing CaSR expression predispose to calcium nephrolithiasis Bone. 51. DOI: 10.1016/J.Bone.2012.08.087 |
0.39 |
|
| 2011 |
Puzhko S, Goodyer CG, Kerachian MA, Canaff L, Misra M, Jüppner H, Bastepe M, Hendy GN. Parathyroid hormone signaling via Gαs is selectively inhibited by an NH(2)-terminally truncated Gαs: implications for pseudohypoparathyroidism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2473-85. PMID 21713996 DOI: 10.1002/Jbmr.461 |
0.387 |
|
| 2011 |
Reh CM, Hendy GN, Cole DE, Jeandron DD. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet. The Journal of Clinical Endocrinology and Metabolism. 96: E707-12. PMID 21289269 DOI: 10.1210/Jc.2010-1306 |
0.444 |
|
| 2011 |
Hisa I, Inoue Y, Hendy GN, Canaff L, Kitazawa R, Kitazawa S, Komori T, Sugimoto T, Seino S, Kaji H. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway. The Journal of Biological Chemistry. 286: 9787-96. PMID 21239498 DOI: 10.1074/Jbc.M110.179127 |
0.335 |
|
| 2011 |
Vezzoli G, Scillitani A, Corbetta S, Terranegra A, Dogliotti E, Guarnieri V, Arcidiacono T, Paloschi V, Rainone F, Eller-Vainicher C, Borghi L, Nouvenne A, Guerra A, Meschi T, Allegri F, ... ... Hendy GN, et al. Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism. European Journal of Endocrinology / European Federation of Endocrine Societies. 164: 421-7. PMID 21183554 DOI: 10.1530/Eje-10-0915 |
0.373 |
|
| 2010 |
Richard C, Huo R, Samadfam R, Bolivar I, Miao D, Brown EM, Hendy GN, Goltzman D. The calcium-sensing receptor and 25-hydroxyvitamin D-1alpha-hydroxylase interact to modulate skeletal growth and bone turnover. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 1627-36. PMID 20200973 DOI: 10.1002/Jbmr.58 |
0.375 |
|
| 2010 |
Guarnieri V, Canaff L, Yun FH, Scillitani A, Battista C, Muscarella LA, Wong BY, Notarangelo A, D'Agruma L, Sacco M, Cole DE, Hendy GN. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years. The Journal of Clinical Endocrinology and Metabolism. 95: 1819-29. PMID 20164288 DOI: 10.1210/Jc.2008-2430 |
0.447 |
|
| 2010 |
Patterson EK, Hodsman AB, Hendy GN, Canaff L, Bringhurst FR, Fraher LJ. Functional analysis of a type 1 parathyroid hormone receptor intracellular tail mutant [KRK(484-6)AAA]: effects on second messenger generation and cellular targeting. Bone. 46: 1180-7. PMID 20006743 DOI: 10.1016/J.Bone.2009.12.005 |
0.399 |
|
| 2009 |
Hendy GN, Guarnieri V, Canaff L. Calcium-sensing receptor and associated diseases. Progress in Molecular Biology and Translational Science. 89: 31-95. PMID 20374733 DOI: 10.1016/S1877-1173(09)89003-0 |
0.483 |
|
| 2009 |
Cole DE, Yun FH, Wong BY, Shuen AY, Booth RA, Scillitani A, Pidasheva S, Zhou X, Canaff L, Hendy GN. Calcium-sensing receptor mutations and denaturing high performance liquid chromatography. Journal of Molecular Endocrinology. 42: 331-9. PMID 19179454 DOI: 10.1677/Jme-08-0164 |
0.446 |
|
| 2009 |
Canaff L, Zhou X, Mosesova I, Cole DE, Hendy GN. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism. Human Mutation. 30: 85-92. PMID 18712808 DOI: 10.1002/Humu.20827 |
0.478 |
|
| 2008 |
Canaff L, Zhou X, Hendy GN. The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3. The Journal of Biological Chemistry. 283: 13586-600. PMID 18348986 DOI: 10.1074/Jbc.M708087200 |
0.386 |
|
| 2007 |
Patterson EK, Watson PH, Hodsman AB, Hendy GN, Canaff L, Bringhurst FR, Poschwatta CH, Fraher LJ. Expression of PTH1R constructs in LLC-PK1 cells: protein nuclear targeting is mediated by the PTH1R NLS. Bone. 41: 603-10. PMID 17627912 DOI: 10.1016/J.Bone.2007.04.201 |
0.302 |
|
| 2007 |
Zajickova K, Vrbikova J, Canaff L, Pawelek PD, Goltzman D, Hendy GN. Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status. The Journal of Clinical Endocrinology and Metabolism. 92: 2616-23. PMID 17473068 DOI: 10.1210/Jc.2007-0123 |
0.476 |
|
| 2007 |
Yun FH, Wong BY, Chase M, Shuen AY, Canaff L, Thongthai K, Siminovitch K, Hendy GN, Cole DE. Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnostics. Clinical Biochemistry. 40: 551-61. PMID 17320849 DOI: 10.1016/J.Clinbiochem.2006.12.011 |
0.431 |
|
| 2007 |
Ali A, Christie PT, Grigorieva IV, Harding B, Van Esch H, Ahmed SF, Bitner-Glindzicz M, Blind E, Bloch C, Christin P, Clayton P, Gecz J, Gilbert-Dussardier B, Guillen-Navarro E, Hackett A, ... ... Hendy GN, et al. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Human Molecular Genetics. 16: 265-75. PMID 17210674 DOI: 10.1093/Hmg/Ddl454 |
0.376 |
|
| 2007 |
Scillitani A, Guarnieri V, Battista C, De Geronimo S, Muscarella LA, Chiodini I, Cignarelli M, Minisola S, Bertoldo F, Francucci CM, Malavolta N, Piovesan A, Mascia ML, Muscarella S, Hendy GN, et al. Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptor. The Journal of Clinical Endocrinology and Metabolism. 92: 277-83. PMID 17018660 DOI: 10.1210/Jc.2006-0857 |
0.41 |
|
| 2006 |
Naito J, Kaji H, Sowa H, Kitazawa R, Kitazawa S, Tsukada T, Hendy GN, Sugimoto T, Chihara K. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene. Endocrine. 29: 485-90. PMID 16943588 DOI: 10.1385/Endo:29:3:485 |
0.362 |
|
| 2006 |
Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U, Hendy GN. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Human Molecular Genetics. 15: 2200-9. PMID 16740594 DOI: 10.1093/Hmg/Ddl145 |
0.388 |
|
| 2006 |
Mittelman SD, Hendy GN, Fefferman RA, Canaff L, Mosesova I, Cole DE, Burkett L, Geffner ME. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. The Journal of Clinical Endocrinology and Metabolism. 91: 2474-9. PMID 16608894 DOI: 10.1210/Jc.2005-2605 |
0.459 |
|
| 2006 |
Hendy GN, Li T, Girard M, Feldstein RC, Mulay S, Desjardins R, Day R, Karaplis AC, Tremblay ML, Canaff L. Targeted ablation of the chromogranin A (Chga) gene: Normal neuroendocrine dense-core secretory granules and increased expression of other granins Molecular Endocrinology. 20: 1935-1947. PMID 16556729 DOI: 10.1210/Me.2005-0398 |
0.369 |
|
| 2006 |
Scillitani A, Jang C, Wong BY, Hendy GN, Cole DE. A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women. Human Genetics. 119: 416-21. PMID 16508749 DOI: 10.1007/S00439-006-0155-8 |
0.324 |
|
| 2006 |
Linglart A, Mahon MJ, Kerachian MA, Berlach DM, Hendy GN, Jüppner H, Bastepe M. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas. Endocrinology. 147: 2253-62. PMID 16484323 DOI: 10.1210/En.2005-1487 |
0.401 |
|
| 2006 |
Hendy GN, Hruska KA, Mathew S, Goltzman D. New insights into mineral and skeletal regulation by active forms of vitamin D Kidney International. 69: 218-223. PMID 16408109 DOI: 10.1038/Sj.Ki.5000091 |
0.366 |
|
| 2005 |
Hendy GN, Kaji H, Sowa H, Lebrun J-, Canaff L. Menin and TGF-β Superfamily Member Signaling via the Smad Pathway in Pituitary, Parathyroid and Osteoblast Hormone and Metabolic Research. 37: 375-379. PMID 16001330 DOI: 10.1055/S-2005-870152 |
0.309 |
|
| 2005 |
Hendy GN, Goltzman D. Does calcitriol have actions independent from the vitamin D receptor in maintaining skeletal and mineral homeostasis? Current Opinion in Nephrology and Hypertension. 14: 350-4. PMID 15931003 DOI: 10.1097/01.Mnh.0000172721.44875.24 |
0.314 |
|
| 2005 |
Pidasheva S, Canaff L, Simonds WF, Marx SJ, Hendy GN. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia. Human Molecular Genetics. 14: 1679-90. PMID 15879434 DOI: 10.1093/Hmg/Ddi176 |
0.42 |
|
| 2005 |
Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Human Molecular Genetics. 14: 1515-28. PMID 15843402 DOI: 10.1093/Hmg/Ddi160 |
0.375 |
|
| 2005 |
Canaff L, Hendy GN. Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elements. The Journal of Biological Chemistry. 280: 14177-88. PMID 15684428 DOI: 10.1074/Jbc.M408587200 |
0.413 |
|
| 2005 |
Wystrychowski A, Pidasheva S, Canaff L, Chudek J, Kokot F, Wiecek A, Hendy GN. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 90: 864-70. PMID 15572418 DOI: 10.1210/Jc.2004-1791 |
0.475 |
|
| 2005 |
Naito J, Kaji H, Sowa H, Hendy GN, Sugimoto T, Chihara K. Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD. The Journal of Biological Chemistry. 280: 4785-91. PMID 15563473 DOI: 10.1074/Jbc.M408143200 |
0.328 |
|
| 2004 |
Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, Bertoldo F, Florio C, Minisola S, Hendy GN, Cole DE. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. The Journal of Clinical Endocrinology and Metabolism. 89: 5634-8. PMID 15531522 DOI: 10.1210/Jc.2004-0129 |
0.329 |
|
| 2004 |
Pidasheva S, D'Souza-Li L, Canaff L, Cole DE, Hendy GN. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Human Mutation. 24: 107-11. PMID 15241791 DOI: 10.1002/Humu.20067 |
0.738 |
|
| 2004 |
Pagan YL, Hirschhorn J, Yang B, D'Souza-Li L, Majzoub JA, Hendy GN. Maternal activating mutation of the calcium-sensing receptor: implications for calcium metabolism in the neonate. Journal of Pediatric Endocrinology & Metabolism : Jpem. 17: 673-7. PMID 15198301 DOI: 10.1515/Jpem.2004.17.4.673 |
0.741 |
|
| 2004 |
Sowa H, Kaji H, Hendy GN, Canaff L, Komori T, Sugimoto T, Chihara K. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. The Journal of Biological Chemistry. 279: 40267-75. PMID 15150273 DOI: 10.1074/Jbc.M401312200 |
0.313 |
|
| 2004 |
Lacerte A, Lee EH, Reynaud R, Canaff L, De Guise C, Devost D, Ali S, Hendy GN, Lebrun JJ. Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. Molecular Endocrinology (Baltimore, Md.). 18: 1558-69. PMID 15031321 DOI: 10.1210/Me.2003-0470 |
0.315 |
|
| 2004 |
Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. The Journal of Biological Chemistry. 279: 16754-66. PMID 14739296 DOI: 10.1074/Jbc.M310271200 |
0.392 |
|
| 2004 |
Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. The Journal of Clinical Endocrinology and Metabolism. 89: 96-102. PMID 14715834 DOI: 10.1210/Jc.2003-030675 |
0.386 |
|
| 2003 |
Bastepe M, Fröhlich LF, Hendy GN, Indridason OS, Josse RG, Koshiyama H, Körkkö J, Nakamoto JM, Rosenbloom AL, Slyper AH, Sugimoto T, Tsatsoulis A, Crawford JD, Jüppner H. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. The Journal of Clinical Investigation. 112: 1255-63. PMID 14561710 DOI: 10.1172/Jci19159 |
0.354 |
|
| 2003 |
Hendy GN, Minutti C, Canaff L, Pidasheva S, Yang B, Nouhi Z, Zimmerman D, Wei C, Cole DE. Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene. The Journal of Clinical Endocrinology and Metabolism. 88: 3674-81. PMID 12915654 DOI: 10.1210/Jc.2003-030409 |
0.475 |
|
| 2003 |
Sowa H, Kaji H, Canaff L, Hendy GN, Tsukamoto T, Yamaguchi T, Miyazono K, Sugimoto T, Chihara K. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. The Journal of Biological Chemistry. 278: 21058-69. PMID 12649288 DOI: 10.1074/Jbc.M302044200 |
0.329 |
|
| 2003 |
Kifor O, Moore FD, Delaney M, Garber J, Hendy GN, Butters R, Gao P, Cantor TL, Kifor I, Brown EM, Wysolmerski J. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. The Journal of Clinical Endocrinology and Metabolism. 88: 60-72. PMID 12519831 DOI: 10.1210/Jc.2002-020249 |
0.388 |
|
| 2002 |
Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. The Journal of Biological Chemistry. 277: 30337-50. PMID 12036954 DOI: 10.1074/Jbc.M201804200 |
0.419 |
|
| 2002 |
Minagawa M, Yasuda T, Watanabe T, Minamitani K, Takahashi Y, Goltzman D, White JH, Hendy GN, Kohno Y. Association between AAAG repeat polymorphism in the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene and adult height, urinary pyridinoline excretion, and promoter activity. The Journal of Clinical Endocrinology and Metabolism. 87: 1791-6. PMID 11932319 DOI: 10.1210/Jcem.87.4.8419 |
0.356 |
|
| 2002 |
D'Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, Salisbury SR, Brown EM, Cole DE, Hendy GN. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. The Journal of Clinical Endocrinology and Metabolism. 87: 1309-18. PMID 11889203 DOI: 10.1210/Jcem.87.3.8280 |
0.753 |
|
| 2002 |
Hotte SJ, Hirte HW, Rabbani SA, Carling T, Hendy GN, Major PP. Hypercalcemia of Malignancy American Journal of Cancer. 1: 179-187. DOI: 10.2165/00024669-200201030-00003 |
0.367 |
|
| 2001 |
D'Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Human Mutation. 18: 411-21. PMID 11668634 DOI: 10.1002/Humu.1212 |
0.753 |
|
| 2001 |
Zheng H, Radeva G, McCann JA, Hendy GN, Goodyer CG. Gαs transcripts are biallelically expressed in the human kidney cortex: Implications for pseudohypoparathyroidism type 1b Journal of Clinical Endocrinology and Metabolism. 86: 4627-4629. PMID 11600515 DOI: 10.1210/Jcem.86.10.7940 |
0.312 |
|
| 2001 |
Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proceedings of the National Academy of Sciences of the United States of America. 98: 7498-503. PMID 11416220 DOI: 10.1073/Pnas.131029498 |
0.314 |
|
| 2001 |
Ritchie G, Kerstan D, Dai L, Kang HS, Canaff L, Hendy GN, Quamme GA. 1,25(OH)2D3 stimulates Mg2+uptake into MDCT cells: modulation by extracellular Ca2+and Mg2+ American Journal of Physiology-Renal Physiology. 280. PMID 11292630 DOI: 10.1152/Ajprenal.2001.280.5.F868 |
0.317 |
|
| 2001 |
Kaji H, Canaff L, Lebrun J, Goltzman D, Hendy GN. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling Proceedings of the National Academy of Sciences of the United States of America. 98: 3837-3842. PMID 11274402 DOI: 10.1073/Pnas.061358098 |
0.32 |
|
| 2001 |
Minagawa M, Watanabe T, Kohno Y, Mochizuki H, Hendy GN, Goltzman D, White JH, Yasuda T. Analysis of the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene in pseudohypoparathyroidism type 1b. The Journal of Clinical Endocrinology and Metabolism. 86: 1394-7. PMID 11238537 DOI: 10.1210/Jcem.86.3.7364 |
0.363 |
|
| 2001 |
Cole DE, Vieth R, Trang HM, Wong BY, Hendy GN, Rubin LA. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Molecular Genetics and Metabolism. 72: 168-74. PMID 11161843 DOI: 10.1006/Mgme.2000.3126 |
0.403 |
|
| 2001 |
Panda DK, Kawas SA, Seldin MF, Hendy GN, Goltzman D. 25-Hydroxyvitamin D 1α-hydroxylase: Structure of the mouse gene, chromosomal assignment, and developmental expression Journal of Bone and Mineral Research. 16: 46-56. PMID 11149489 DOI: 10.1359/Jbmr.2001.16.1.46 |
0.349 |
|
| 2000 |
Hendy GN. Molecular mechanisms of primary hyperparathyroidism. Reviews in Endocrine & Metabolic Disorders. 1: 297-305. PMID 11706744 DOI: 10.1023/A:1026518502081 |
0.396 |
|
| 2000 |
Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Human Mutation. 16: 281-96. PMID 11013439 DOI: 10.1002/1098-1004(200010)16:4<281::Aid-Humu1>3.0.Co;2-A |
0.764 |
|
| 2000 |
Minagawa M, Kwan MY, Bettoun JD, Mansour FW, Dassa J, Hendy GN, Goltzman D, White JH. Dissection of differentially regulated (G+C)-rich promoters of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. Endocrinology. 141: 2410-21. PMID 10875241 DOI: 10.1210/Endo.141.7.7559 |
0.327 |
|
| 2000 |
Watson PH, Fraher LJ, Hendy GN, Chung UI, Kisiel M, Natale BV, Hodsman AB. Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 15: 1033-44. PMID 10841172 DOI: 10.1359/Jbmr.2000.15.6.1033 |
0.346 |
|
| 2000 |
Watson PH, Fraher LJ, Natale BV, Kisiel M, Hendy GN, Hodsman AB. Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation. Bone. 26: 221-5. PMID 10709993 DOI: 10.1016/S8756-3282(99)00264-1 |
0.324 |
|
| 2000 |
Bettoun JD, Kwan MY, Minagawa M, Alpert LC, Goodyer CG, Hendy GN, Goltzman D, White JH. Methylation patterns of human parathyroid hormone (PTH)/PTH-related peptide receptor gene promoters are established several weeks prior to onset of their function. Biochemical and Biophysical Research Communications. 267: 482-7. PMID 10631087 DOI: 10.1006/Bbrc.1999.1982 |
0.315 |
|
| 1999 |
Canaff L, Bennett HPJ, Hendy GN. Peptide hormone precursor processing: getting sorted? Molecular and Cellular Endocrinology. 156: 1-6. PMID 10612417 DOI: 10.1016/S0303-7207(99)00129-X |
0.332 |
|
| 1999 |
Karmali R, Wolf ND, Beyer I, Hendy G, Bergmann P. 1,25-Dihydroxyvitamin D3 inhibits parathyroid hormone-related peptide mRNA expression in fetal rat long bones in culture In Vitro Cellular & Developmental Biology – Animal. 35: 296-298. PMID 10475276 DOI: 10.1007/S11626-999-0074-9 |
0.31 |
|
| 1999 |
Fraher LJ, Avram R, Watson PH, Hendy GN, Henderson JE, Chong KL, Goltzman D, Morley P, Willick GE, Whitfield JF, Hodsman AB. Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans Journal of Clinical Endocrinology and Metabolism. 84: 2739-2743. PMID 10443671 DOI: 10.1210/Jcem.84.8.5891 |
0.371 |
|
| 1999 |
Zogopoulos G, Nathanielsz P, Hendy G, Goodyer C. The baboon: a model for the study of primate growth hormone receptor gene expression during development. Journal of Molecular Endocrinology. 23: 67-75. PMID 10425448 DOI: 10.1677/Jme.0.0230067 |
0.316 |
|
| 1999 |
Cole DE, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, Hwang DM, Evrovski J, Hendy GN. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet (London, England). 353: 112-5. PMID 10023897 DOI: 10.1016/S0140-6736(98)06434-4 |
0.434 |
|
| 1998 |
Jüppner H, Schipani E, Bastepe M, Cole DE, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T, Crawford JD, Olsen BR, Vikkula M. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proceedings of the National Academy of Sciences of the United States of America. 95: 11798-803. PMID 9751745 DOI: 10.1073/Pnas.95.20.11798 |
0.391 |
|
| 1998 |
Bettoun JD, Minagawa M, Hendy GN, Alpert LC, Goodyer CG, Goltzman D, White JH. Developmental upregulation of human parathyroid hormone (PTH)/PTH-related peptide receptor gene expression from conserved and human-specific promoters. The Journal of Clinical Investigation. 102: 958-67. PMID 9727064 DOI: 10.1172/Jci3678 |
0.365 |
|
| 1998 |
Bapty BW, Dai LJ, Ritchie G, Jirik F, Canaff L, Hendy GN, Quamme GA. Extracellular Mg2+- and Ca2+-sensing in mouse distal convoluted tubule cells Kidney International. 53: 583-592. PMID 9507202 DOI: 10.1046/J.1523-1755.1998.00790.X |
0.337 |
|
| 1998 |
Canaff L, Bevan S, Wheeler DG, Mouland AJ, Rehfuss RP, White JH, Hendy GN. Analysis of molecular mechanisms controlling neuroendocrine cell specific transcription of the chromogranin A gene. Endocrinology. 139: 1184-96. PMID 9492053 DOI: 10.1210/Endo.139.3.5851 |
0.399 |
|
| 1997 |
Rabbani SA, Harakidas P, Gladu J, Srivastava S, Diarra A, Sauvé R, Karaplis AC, Henderson JE, Goltzman D, Hendy GN. Expression and characterization of recombinant rat parathyroid hormone-related peptide (1-141) and an amino-terminally-truncated analogue (38-141) Molecular and Cellular Endocrinology. 130: 13-21. PMID 9220017 DOI: 10.1016/S0303-7207(97)00068-3 |
0.366 |
|
| 1997 |
Cole DEC, Janicic N, Salisbury SR, Hendy GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia : multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene American Journal of Medical Genetics. 71: 202-210. PMID 9217223 DOI: 10.1002/(Sici)1096-8628(19970808)71:2<202::Aid-Ajmg16>3.0.Co;2-I |
0.43 |
|
| 1997 |
Soliman E, Canaff L, Fox J, Hendy GN. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency. Endocrinology. 138: 2596-2600. PMID 9165053 DOI: 10.1210/Endo.138.6.5181 |
0.326 |
|
| 1997 |
Bai M, Janicic N, Trivedi S, Quinn SJ, Cole DEC, Brown EM, Hendy GN. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Journal of Clinical Investigation. 99: 1917-1925. PMID 9109436 DOI: 10.1172/Jci119359 |
0.469 |
|
| 1997 |
Bettoun JD, Minagawa M, Kwan MY, Lee HS, Yasuda T, Hendy GN, Goltzman D, White JH. Cloning and characterization of the promoter regions of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene: analysis of deoxyribonucleic acid from normal subjects and patients with pseudohypoparathyroidism type 1b. The Journal of Clinical Endocrinology and Metabolism. 82: 1031-40. PMID 9100569 DOI: 10.1210/Jcem.82.4.3906 |
0.388 |
|
| 1997 |
Demers C, Lemay J, Hendy GN, Gascon-Barré M. Comparative in vivo expression of the calcitriol-24-hydroxylase gene in kidney and intestine Journal of Molecular Endocrinology. 18: 37-48. PMID 9061605 DOI: 10.1677/Jme.0.0180037 |
0.322 |
|
| 1997 |
Lemay J, Demers C, Hendy GN, Gascon-Barré M. Oral calcium transiently increases calbindin(9k) gene expression in adult rat duodena Calcified Tissue International. 60: 43-47. PMID 9030479 DOI: 10.1007/S002239900184 |
0.385 |
|
| 1997 |
Amizuka N, Lee HS, Kwan MY, Arazani A, Warshawsky H, Hendy GN, Ozawa H, White JH, Goltzman D. Cell-specific expression of the parathyroid hormone (PTH)/PTH-related peptide receptor gene in kidney from kidney-specific and ubiquitous promoters. Endocrinology. 138: 469-81. PMID 8977437 DOI: 10.1210/Endo.138.1.4845 |
0.361 |
|
| 1997 |
Rubin LA, Peltekova V, Janicic N, Liew CC, Hwang D, Evrovski J, Hendy GN, Cole DEC. Calcium sensing receptor gene: analysis of polymorphism frequency Scandinavian Journal of Clinical & Laboratory Investigation. 57: 122-125. DOI: 10.1080/00365519709168318 |
0.444 |
|
| 1996 |
Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, Ploos Van Amstel HK, Lips CJM, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, ... ... Hendy GN, et al. The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET mutation consortium analysis Journal of the American Medical Association. 276: 1575-1579. PMID 8918855 DOI: 10.1001/Jama.276.19.1575 |
0.367 |
|
| 1996 |
Pausova Z, Soliman E, Amizuka N, Janicic N, Konrad EM, Arnold A, Goltzman D, Hendy GN. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. The Journal of Clinical Endocrinology and Metabolism. 81: 2711-8. PMID 8675600 DOI: 10.1210/Jcem.81.7.8675600 |
0.349 |
|
| 1996 |
Kremer R, Sebag M, Champigny C, Meerovitch K, Hendy GN, White J, Goltzman D. Identification and characterization of 1,25-dihydroxyvitamin D3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene. Journal of Biological Chemistry. 271: 16310-16316. PMID 8663213 DOI: 10.1074/Jbc.271.27.16310 |
0.365 |
|
| 1996 |
Janicic N, Soliman E, Pausova Z, Seldin MF, Rivière M, Szpirer J, Szpirer C, Hendy GN. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 6: 798-801. PMID 8597637 DOI: 10.1007/Bf00539007 |
0.399 |
|
| 1995 |
Lemay J, Demers C, Hendy GN, Delvin EE, Gascon‐Barré M. Expression of the 1,25‐dihydroxyvitamin D3‐24‐hydroxylase gene in rat intestine: Response to calcium, vitamin D3 and calcitriol administration in vivo Journal of Bone and Mineral Research. 10: 1148-1157. PMID 8585417 DOI: 10.1002/Jbmr.5650100803 |
0.354 |
|
| 1995 |
Hendy GN, Bennett HP, Gibbs BF, Lazure C, Day R, Seidah NG. Proparathyroid hormone is preferentially cleaved to parathyroid hormone by the prohormone convertase furin. A mass spectrometric study. The Journal of Biological Chemistry. 270: 9517-25. PMID 7721880 DOI: 10.1074/Jbc.270.16.9517 |
0.368 |
|
| 1995 |
Wheeler DG, Horsford J, Michalak M, White JH, Hendy GN. Calreticulin inhibits vitamin D3 signal transduction. Nucleic Acids Research. 23: 3268-74. PMID 7667104 DOI: 10.1093/Nar/23.16.3268 |
0.326 |
|
| 1995 |
Pollak MR, Chou YW, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism Pediatric Nephrology. 9: 297-297. DOI: 10.1016/B978-0-12-397166-1.00024-2 |
0.457 |
|
| 1994 |
Pollak MR, Chou YHW, Marx SJ, Steinmann B, Cole DEC, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman CE, Seidman JG. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism: Effects of mutant gene dosage on phenotype Journal of Clinical Investigation. 93: 1108-1112. PMID 8132750 DOI: 10.1007/Bf02254188 |
0.348 |
|
| 1993 |
Pausova Z, Morgan K, Fujiwara TM, Bourdon J, Goltzman D, Hendy GN. Molecular characterization of an intragenic minisatellite (VNTR) polymorphism in the human parathyroid hormone-related peptide gene in chromosome region 12p12.1-p11.2. Genomics. 17: 243-4. PMID 8406461 DOI: 10.1006/Geno.1993.1313 |
0.332 |
|
| 1993 |
Ethier C, Goupil D, Demers C, Hendy GN, Gascon-Barre M. Hypocalcemia, regardless of the vitamin D status, decreases epidermal growth factor receptor density and autophosphorylation in rat livers Endocrinology. 133: 780-792. PMID 8393775 DOI: 10.1210/Endo.133.2.8393775 |
0.358 |
|
| 1993 |
Bichet DG, Arthus MF, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. Journal of Clinical Investigation. 92: 1262-1268. PMID 8104196 DOI: 10.1172/Jci116698 |
0.376 |
|
| 1992 |
Löwik CW, Hoekman K, Offringa R, Groot CG, Hendy GN, Papapoulos SE, Ponec M. Regulation of parathyroid hormonelike protein production in cultured normal and malignant keratinocytes. The Journal of Investigative Dermatology. 98: 198-203. PMID 1732383 DOI: 10.1111/1523-1747.Ep12555864 |
0.357 |
|
| 1992 |
Karmali R, Schiffmann SN, Vanderwinden J, Hendy GN, Nys-DeWolf N, corvilain J, Bergmann P, Vanderhaeghen J. Expression of mRNA of parathyroid hormone-related peptide in fetal bones of the rat. Cell and Tissue Research. 270: 597-600. PMID 1486610 DOI: 10.1007/Bf00645063 |
0.318 |
|
| 1991 |
Kremer R, Karaplis AC, Henderson J, Gulliver W, Banville D, Hendy GN, Goltzman D. Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes: Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion Journal of Clinical Investigation. 87: 884-893. PMID 1999499 DOI: 10.1172/Jci115094 |
0.394 |
|
| 1991 |
Mouland AJ, Hendy GN. Regulation of synthesis and secretion of chromogranin-A by calcium and 1,25-dihydroxycholecalciferol in cultured bovine parathyroid cells. Endocrinology. 128: 441-449. PMID 1986936 DOI: 10.1210/Endo-128-1-441 |
0.384 |
|
| 1991 |
Zaman G, Saphier PW, Loveridge N, Kimura T, Sakakibara S, Bernier SM, Hendy GN. Biological properties of synthetic human parathyroid hormone: Effect of deamidation at position 76 on agonist and antagonist activity Endocrinology. 128: 2583-2590. PMID 1850358 DOI: 10.1210/Endo-128-5-2583 |
0.336 |
|
| 1991 |
Kongo T, Kupfer J, Enomoto H, Sharifi B, Giannella-Neto D, Forrester JS, Singer FR, Goltzman D, Hendy GN, Pirola C, Fagin JA, Clemens TL. Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation Journal of Clinical Investigation. 88: 1841-1847. PMID 1752945 DOI: 10.1172/Jci115505 |
0.354 |
|
| 1990 |
Karaplis AC, Yasuda T, Hendy GN, Goltzman D, Banville D. Gene-encoding parathyroid hormone-like peptide: nucleotide sequence of the rat gene and comparison with the human homologue. Molecular Endocrinology (Baltimore, Md.). 4: 441-6. PMID 2342478 DOI: 10.1210/Mend-4-3-441 |
0.36 |
|
| 1990 |
Rabbani SA, Kaiser SM, Henderson JE, Bernier SM, Mouland AJ, Roy DR, Zahab DM, Sung WL, Goltzman D, Hendy GN. Synthesis and characterization of extended and deleted recombinant analogues of parathyroid hormone-(1-84): correlation of peptide structure with function. Biochemistry. 29: 10080-9. PMID 2176861 DOI: 10.1021/Bi00495A010 |
0.387 |
|
| 1990 |
Hendy GN, Sakaguchi AY, Lalley PA, Martinez L, Yasuda T, Banville D, Goltzman D. Gene for parathyroid hormone-like peptide is on mouse chromosome 6. Cytogenetic and Genome Research. 53: 80-82. PMID 1973379 DOI: 10.1159/000132899 |
0.335 |
|
| 1989 |
Goltzman D, Hendy GN, Banville D. Parathyroid hormone-like peptide: molecular characterization and biological properties. Trends in Endocrinology and Metabolism. 1: 39-44. PMID 18411086 DOI: 10.1016/1043-2760(89)90029-5 |
0.371 |
|
| 1989 |
Clemens TL, McGlade SA, Garrett KP, Craviso GL, Hendy GN. Extracellular Calcium Modulates Vitamin D-Dependent Calbindin-D28K Gene Expression In Chick Kidney Cells Endocrinology. 124: 1582-1584. PMID 2917526 DOI: 10.1210/Endo-124-3-1582 |
0.368 |
|
| 1989 |
Rabbani SA, Mitchell J, Roy DR, Hendy GN, Goltzman D. Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy. Endocrinology. 123: 2709-16. PMID 2848683 DOI: 10.1210/Endo-123-6-2709 |
0.367 |
|
| 1989 |
Yasuda T, Banville D, Rabbani SA, Hendy GN, Goltzman D. Rat parathyroid hormone-like peptide: comparison with the human homologue and expression in malignant and normal tissue. Molecular Endocrinology (Baltimore, Md.). 3: 518-25. PMID 2747658 DOI: 10.1210/Mend-3-3-518 |
0.324 |
|
| 1989 |
Hendy GN, Stotland MA, Grunbaum D, Fraher LJ, Loveridge N, Goltzman D. Characteristics of secondary hyperparathyroidism in vitamin D-deficient dogs. The American Journal of Physiology. 256: E765-72. PMID 2735402 DOI: 10.1152/Ajpendo.1989.256.6.E765 |
0.343 |
|
| 1989 |
Kremer R, Bolivar I, Goltzman D, Hendy GN. Influence of Calcium and 1,25-Dihydroxycholecalciferol on Proliferation and Proto-Oncogene Expression in Primary Cultures of Bovine Parathyroid Cells* Endocrinology. 125: 935-941. PMID 2502380 DOI: 10.1210/Endo-125-2-935 |
0.371 |
|
| 1988 |
Born W, Freeman M, Bornstein W, Rapoport A, Klein RD, Hendy GN, Khorana HG, Rich A, Potts JT, Kronenberg HM. Signal sequence of human preproparathyroid hormone is inactive in yeast. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 2: 353-60. PMID 3455619 DOI: 10.1002/Jbmr.5650020413 |
0.341 |
|
| 1988 |
Farrow SM, Karmali R, Gleed JH, Hendy GN, O'Riordan JL. Regulation of preproparathyroid hormone messenger RNA and hormone synthesis in human parathyroid adenomata. The Journal of Endocrinology. 117: 133-8. PMID 3356955 DOI: 10.1677/Joe.0.1170133 |
0.39 |
|
| 1988 |
Born W, Freeman M, Hendy GN, Rapoport A, Rich A, Potts JT, Kronenberg HM. Human preproparathyroid hormone synthesized in Escherichia coli is transported to the surface of the bacterial inner membrane but not processed to the mature hormone. Molecular Endocrinology (Baltimore, Md.). 1: 5-14. PMID 3331711 DOI: 10.1210/Mend-1-1-5 |
0.307 |
|
| 1988 |
Hendy GN, Sakaguchi AY, Yasuda T, Weber DK, Wang LM, Yoshida MC, Banville D, Goltzman D. Gene for parathyroid hormone-like peptide is on rat chromosome 2 Biochemical and Biophysical Research Communications. 157: 558-562. PMID 3202868 DOI: 10.1016/S0006-291X(88)80285-7 |
0.31 |
|
| 1988 |
Bergada I, Schiffrin A, Srair HA, Kaplan P, Dornan J, Goltzman D, Hendy GN. Kenny syndrome: description of additional abnormalities and molecular studies. Human Genetics. 80: 39-42. PMID 2843457 DOI: 10.1007/Bf00451452 |
0.303 |
|
| 1986 |
Brookman JJ, Farrow SM, Nicholson L, O'Riordan JL, Hendy GN. Regulation by calcium of parathyroid hormone mRNA in cultured parathyroid tissue. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 1: 529-37. PMID 2459912 DOI: 10.1002/Jbmr.5650010607 |
0.361 |
|
| 1982 |
Lewin IG, Papapoulos SE, Hendy GN, Tomlinson S, O'Riordan JL. Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency. Clinical Science (London, England : 1979). 62: 381-7. PMID 6279352 DOI: 10.1042/Cs0620381 |
0.319 |
|
| 1980 |
Manning RM, Hendy GN, Papapoulos SE, O'riordan JLH. Development Of Homologous Immunological Assays For Human Parathyroid Hormone Journal of Endocrinology. 85: 161-170. PMID 7391719 DOI: 10.1677/Joe.0.0850161 |
0.316 |
|
| 1979 |
Hendy GN, Manning RM, Rosenblatt M, Tregear GW, Keutmann HT, O'riordan JLH. Immunological properties of synthetic human parathyroid hormone 53--84 fragment. Journal of Endocrinology. 80: 153-155. PMID 429948 DOI: 10.1677/Joe.0.0800153 |
0.313 |
|
| Show low-probability matches. |